Materials and method: In this in vitro study, 90 files (Reciproc, HyFlex CM Pro, Neoniti) were divided into three groups: Group 1 was in the as-received condition, Group 2 and Group 3 were after subjection to 1 and 3 sterilization cycles with simulated clinical use, respectively.